Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
Dividend growth stocks hold considerable appeal for long-term investors because they offer regular income and show potential for capital appreciation as dividends increase over time. Amid this backdrop, it could be wise to keep track of dividend stocks, The Home Depot, Inc. , AbbVie Inc. , and McDonald's Corporation , for long-term growth.
The dividend growth rate is the annualized percentage rate of growth that a particular stock's dividend undergoes over a period of time. Typically, these stocks come from well-established companies with stable earnings, predictable cash flows, and a strong commitment to rewarding shareholders. These companies also seek to increase the dividends paid to their investors on a regular basis.
Historically, companies with strong dividend growth records have shown stability and less volatility than their non-dividend counterparts. The appeal of dividend growth stocks often lies in their resilience, especially during economic downturns.
These stocks also provide a dual advantage for growth-focused investors: while they enjoy income from dividends, they also stand to benefit from share price appreciation. The income produced by dividends may be an essential complement to a strong capital appreciation strategy, as it may limit volatility and contribute to total return over time.
Additionally, on a per share basis, S&P 500 Q3 2024 dividend payments set a record, as payments increased 2.2% to $18.68 per share from Q2 2024's $18.28 and were up 8.3% from Q3 2023's $17.26 payment. Investing in companies with sustainable dividend growth can help augment total returns and reduce volatility while providing a growing income stream.
Given these factors, let’s delve deeper into the fundamentals of top dividend growth stocks: HD, ABBV, and MCD.
The Home Depot, Inc. (HD)
HD operates as a home improvement retailer worldwide. It offers various building materials, home improvement products, lawn and garden products, and décor items, as well as facilities maintenance, repair, and operations products.
On September 12, the company declared a quarterly dividend of $2.25 per share. With 14 years of consecutive dividend growth, HD pays an annual dividend of $9, which translates to a yield of 2.22% at the current share price. Also, the company’s dividend payouts have increased at CAGRs of 11.6% and 11.1% over the past five and three years, respectively.
On June 18, HD completed its acquisition of SRS Distribution, Inc., a leading residential specialty trade distribution company, for a total of approximately $18.25 billion. This acquisition should accelerate HD’s growth and establish it as a leading specialty trade distributor across multiple verticals.
HD’s net sales for the second quarter ended July 28, 2024, and increased marginally year-over-year to $43.18 billion. Meanwhile, its gross profit improved by 1.8% from the prior year’s value to $14.42 billion. The company’s net earnings stood at $4.56 billion, while its EPS came in at $4.60.
According to the fiscal year 2024 guidance, HD forecasts total sales to range between 2.5% to 3.5% and the operating margin rate to be between 13.5%-13.6%. The company also expects 12 new stores.
Street expects HD’s revenue for the fiscal fourth quarter (ending January 2025) to increase 10.8% year-over-year to $38.55 billion. Its EPS for the same period is expected to register a 6.7% growth from the prior year, settling at $3.01. In addition, it surpassed the consensus EPS estimates in each of the trailing four quarters, which is promising.
The stock has gained 37.2% over the past year and 19.8% over the past six months to close the last trading session at $405.90.
HD’s stance is apparent in its POWR Ratings. The stock has a B grade for Stability and Sentiment. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
Among the 57 stocks in the B-rated Home Improvement & Goods industry, it is ranked #31. Click here to see the additional HD ratings (Growth, Value, Momentum, and Quality).
AbbVie Inc. (ABBV)
ABBV is a global, diversified, research-based biopharmaceutical company engaged in the manufacture and sale of medications and therapies. It offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties.
Buoyed by strong financial performance, the company declared its shareholders a quarterly dividend of $1.64 per share, payable February 14, 2025, to common shareholders of record at the close of business on January 15, 2025.
ABBV pays an annual dividend of $6.56, which translates to a yield of 3.29% at the current share price. Its four-year average dividend yield is 3.93%. Moreover, the company’s dividend payouts have increased at a CAGR of 7.7% over the past five years.
On October 28, ABBV announced its acquisition of Aliada Technologies, a biotechnology company advancing therapies using a novel blood-brain barrier (BBB)-crossing technology to address challenging central nervous system (CNS) diseases. This acquisition should help ABBV strengthen its position in the market by bringing ALIA-1758 to patients with Alzheimer's disease.
For the third quarter that ended on September 30, 2024, ABBV’s net revenue increased 3.8% year-over-year to $14.46 billion, while the company’s operating earnings reported $3.83 billion, indicating a 68% growth from the prior-year quarter. ABBV’s adjusted net earnings came in at $5.33 billion, up marginally year-over-year, while its attributable earnings per share grew by 1.7% from the year-ago value to $3.
Looking ahead, ABBV forecasts full-year 2024 and raises its adjusted EPS to range between $10.90 and $10.94, from the prior forecast of $10.67 and $10.87.
The consensus revenue estimate of $14.81 billion for the fiscal fourth quarter (ending December 2024) represents a 3.5% increase year-over-year. The consensus EPS estimate of $2.98 for the current quarter indicates a 6.7% improvement year-over-year. The company has an impressive surprise history; it surpassed the consensus revenue in each of the trailing four quarters.
Shares of ABBV have gained 40.5% over the past year and 24.3% over the past six months to close the last trading session at $199.50.
ABBV’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
It has a B grade for Growth, Value, Stability, Sentiment, and Quality. Out of 160 stocks in the Medical - Pharmaceuticals industry, ABBV is ranked #2. Click here to see ABBV’s rating for Momentum.
McDonald's Corporation (MCD)
MCD operates and franchises restaurants under the McDonald’s brand internationally. The company offers food and beverages, including hamburgers and cheeseburgers, chicken sandwiches, fries, shakes, desserts, sundaes, cookies, pies, soft drinks, coffee, and other beverages.
On September 25, demonstrating its commitment to returning value to shareholders, the company declared the 48th consecutive quarterly dividend of $1.77 per common share. This dividend will be paid on December 16, 2024, to shareholders on record as of December 2, 2024.
MCD pays an annual dividend of $7.08, which translates to a yield of 2.37% at the current share price. Its four-year average dividend yield is 2.2%. Moreover, its dividend payouts have increased at CAGRs of 8.9% and 7.6% over the past three and five years, respectively.
In the fiscal third quarter that ended on September 30, 2024, MCD’s total revenues and others increased 2.5% year-over-year, amounting to $6.87 billion. Its net income came in at $2.26 billion, and its earnings per share stood at $3.13.
Analysts expect MCD’s revenue for the first quarter (ending March 2025) to increase 1.9% year-over-year to $6.29 billion, while its EPS for the same period is expected to grow 3.5% from the prior year’s period to $2.79.
Over the past year, the stock has surged 11.8%, closing the last trading session at $298.97.
MCD’s fundamentals are reflected in its POWR Ratings. The stock has a B grade for Stability and Quality. It is ranked #10 out of 41 stocks in the Restaurants industry.
Beyond what is stated above, we’ve also rated MCD for Growth, Value, Momentum, and Sentiment. Get all MCD’s ratings here.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today’s volatile markets:
3 Stocks to DOUBLE This Year >
HD shares closed at $405.90 on Friday, up $6.46 (+1.62%). Year-to-date, HD has gained 19.37%, versus a 27.04% rise in the benchmark S&P 500 index during the same period.
To become a Dividend King, it takes fifty years of consecutive dividend increases - which is hard to pull off, regardless of company size, sector, or market share. So, there are less than seventy of them today. That’s why joining this elite rank is an achievement—and who doesn’t get excited about stocks that are about to achieve something great?
How I Came Up With The Following Stocks
As a dividend investor, I like to keep tabs on dividend-growth stocks, so I have a watchlist of Dividend Aristocrats (MidCap & S&P 500). After accessing this list, I screened them using the following criteria:
After hitting “See Results,” I got four hits and arranged the results from highest to lowest dividend yields.
Now that I have my list, let’s look at why these companies should be on your radar, starting with the top one.
McDonald's Corporation is a multinational fast-food company and one of the largest restaurant chains in the world, with thousands of locations across over 100 countries. Its business model relies heavily on franchising, where individual operators run McDonald’s restaurants under the brand, contributing to its global presence and profitability.
McDonald’s is still the world's top reigning QSR (quick-service restaurant) based on revenue. And I mean to be honest, even if you don’t like its food, you have to admit the company’s global presence and substantial market share makes it an excellent investment choice.
But its market share isn’t all that McDonald's has going for it. The company also holds the title of Dividend Aristocrat, with a record of 48 consecutive years of increases. The company pays $1.77 per share quarterly, which translates to $7.08 annually and a 2.40% yield.
Chairman and CEO Chris Kempczinski underlines what makes the company thriving despite increasing global competition. “We will stay laser-focused,” he says, “on providing an unparalleled experience with simple, everyday value and affordability that our
consumers can count on as they continue to be mindful about their spending.”
Pentair Ltd. specializes in water treatment and sustainable solutions. It offers a wide range of products and services to help manage, filter, purify, and conserve water.
Pentair’s offerings include residential water filtration systems, pool and spa equipment, industrial water treatment solutions, and commercial filtration systems. The company also focuses on sustainable solutions for water preservation.
The company’s latest quarterly dividend was 23 cents per share. This translates to a 92-cent annual rate and an admittedly less-than-stellar 0.89% yield. Still, the company has a lot of headroom for dividend increases due to its significantly low 21.83% dividend payout ratio. The company is also expected to hike payments in its next quarter, which will mark its 49th year of consecutive dividend increases.
Some people who were aware of Pentair in the late 2010s might wonder how the company had kept its Dividend Aristocrat status when quarterly dividends were 30 cents or more. This is because Pentair spun off its electrical business into nVent Electric plc, which has also increased its dividends since its inception.
Carlisle Companies Inc. is a manufacturing company based in the United States. It is known for providing construction materials and weatherproofing technology focusing on energy efficiency. It used to provide more diversified products and solutions like fluid tech and break and friction systems but has pivoted into a pure-play building products manufacturer in 2018.
The transformation was well-managed and well-received, with the company’s financials and stock performance seeing significant growth afterward.
It’s common for dividend companies to lose their status after such massive operational changes. We saw it with 3M Company (when it spun off Solventum and slashed its dividend) and Telephone and Data Systems (when it cut its dividends to support its 5G business venture).
However, Carlisle Companies continued to increase its dividends despite these changes. The company recently increased payouts from 85 cents to $1.00 per share quarterly, representing a 0.89% annual yield based on current prices. This is its 48th year of consecutive increases.
Final Thoughts
Reaching Dividend King status is challenging. The companies on this list have demonstrated that they have what it takes to compete on the global stage, and their exceptional commitment to shareholder value makes them top choices for income investors all around. As usual, be sure to do your research before making any investment decisions.
On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Home Depot HD is on track to kick off the Q3 earnings season for the conventional brick-and-mortar retailers this week, with the company on deck to report results before the market’s open on Tuesday, November 12th. Lowe’s LOW comes out a week later on Tuesday, November 19th.
Lowe’s shares have outperformed Home Depot this year (+21.6% vs. +16.8%), though both have lagged the Zacks Construction sector (+26.4%) as well as the S&P 500 index (+25.7%), as the chart below shows.
The operating environment for Home Depot and Lowe’s remains difficult, as the interest rate backdrop continues to be unfavorable despite the U.S. Fed’s easing policy. The strength in treasury yields in recent weeks likely reflected the bond market’s early read on the U.S. elections and the incoming administration’s pro-growth policy posture.
With the Fed on track to continue easing, as reconfirmed by the Fed Chair’s press conference, investors would expect treasury yields to eventually come down. That said, the yield curve is unlikely to shift down in parallel, with the shorter end of the curve reflecting the central bank’s easing policy and the longer end proving to be somewhat ‘sticky’ to reflect expectations of a more robust growth environment.
The read-through for Home Depot and Lowe’s of this interest rate discussion is that mortgage rates may not come down as much or as fast as would typically be expected in a Fed easing cycle. What this means is that trends in the existing home sales space are unlikely to meaningfully improve over the near term, though one would expect the medium- to long-term outlook on the existing home sales front to be positive on economic and demographic grounds.
We don’t expect any major surprises in Home Depot’s Q3 results, though the numbers may have benefited on the margin from the active storm activity in the U.S. Southeast. The expectation is for Home Depot’s Q3 earnings to be down -5% from the year-earlier level on +4.1% higher revenues. Estimates for the period are down from three months back, reflecting management’s guidance following the August 13th quarterly report, but they have modestly ticked up in recent days.
With respect to the Retail sector’s 2024 Q3 earnings season scorecard, we now have results from 23 of the 34 retailers in the S&P 500 index. Regular readers know that Zacks has a dedicated stand-alone economic sector for the retail space, which is unlike the placement of the space in the Consumer Staples and Consumer Discretionary sectors in the Standard & Poor’s standard industry classification.
The Zacks Retail sector includes not only Home Depot, Lowe’s, and other traditional retailers, but also online vendors like Amazon AMZN and restaurant players. The 23 Zacks Retail companies in the S&P 500 index that have reported Q3 results already belong to the e-commerce and restaurant industries.
Total Q3 earnings for these 23 retailers that have reported are up +17.3% from the same period last year on +6.3% higher revenues, with 52.2% beating EPS estimates and 47.8% beating revenue estimates.
The comparison charts below put the Q3 beats percentages for these retailers in a historical context.
As you can see above, the online players and restaurant operators have struggled to beat EPS and revenue estimates in Q3. In fact, the Q3 EPS beats percentage for these players represents a new low over the preceding 20 quarters (5 years), while the revenue beats percentage is only modestly above the 20-quarter low and significantly below the 20-quarter average.
Concerning the elevated earnings rate at this stage, we like to show the group’s performance with and without Amazon, whose results are among the 23 companies that have reported already. As we know, Amazon’s Q3 earnings were up +71.6% on +11% higher revenues, beating EPS and revenue expectations.
As we all know, the digital and brick-and-mortar retail spaces have been converging for some time now, with Amazon now a decent-sized brick-and-mortar operator after Whole Foods and Walmart remaining a growing online vendor. As we will see in the days ahead, as Walmart releases quarterly results, the retailer is steadily becoming a big advertising player, thanks to its growing digital business. This long-standing trend got a huge boost from the Covid lockdowns.
The two comparison charts below show the Q3 earnings and revenue growth relative to other recent periods, both with Amazon’s results (left side chart) and without Amazon’s numbers (right side chart)
As you can see above, all of the earnings growth at this stage for the Retail sector is coming from Amazon, with Q3 earnings for the rest of the group that have reported down -10.4% on +3.8% higher revenues. You can see that the top-line growth effectively reflects headline inflationary trends in the economy.
Q3 Earnings Season Scorecard
Through Friday, November 8th, we have seen Q3 results from 452 S&P 500 members, or 90.4% of the index’s total membership. We have another 9 S&P 500 members on deck to report results this week, including Disney, Applied Materials, Shopify, Home Depot, and others.
Total earnings for these 452 companies that have reported are up +7.1% from the same period last year on +5.5% higher revenues, with 73.5% of the companies beating EPS estimates and 61.5% beating revenue estimates.
The proportion of these 452 index members beating both EPS and revenue estimates is 50.7%.
The comparison charts below put the Q3 earnings and revenue growth rates and the EPS and revenue beats percentages in a historical context. The first set of comparison charts show the earnings and revenue growth rates.
The second set of comparison charts compare the Q3 EPS and revenue beats percentages in a historical context.
The comparison charts below spotlight the revenue performance and the blended beats percentage for this group of 452 index members.
As you can see above, the growth trend appears to be stable-to-positive, though fewer companies are able to beat consensus estimates relative to other recent periods. In fact, both the EPS and revenue beats percentages are tracking below the 20-quarter averages for this group of companies.
The Earnings Big Picture
Looking at Q3 as a whole, combining the results that have come out with estimates for the still-to-come companies, total earnings for the S&P 500 index are expected to be up +7.4% from the same period last year on +5.6% higher revenues.
The chart below shows the Q3 earnings and revenue growth pace in the context of where growth has been in the preceding four quarters and what is expected in the coming three quarters.
The Energy and Tech sectors are having the opposite effects on the Q3 earnings growth pace, with the Energy sector dragging it down and the Tech sector pushing it higher.
Had it not been for the Energy sector drag, Q3 earnings for the S&P 500 index would be up +9.9% instead of +7.4%. Excluding the Tech sector’s substantial contribution, Q3 earnings growth for the rest of the index would be up only +2.6% instead of +7.4%.
Excluding the contribution from the Mag 7 group, Q3 earnings for the rest of the 493 S&P 500 members would be up only +2.1% instead of +7.4%.
For the last quarter of the year (2024 Q4), total S&P 500 earnings are expected to be up +8.1% from the same period last year on +4.9% higher revenues.
Unlike the unusually high magnitude of estimate cuts that we had seen ahead of the start of the Q3 earnings season, estimates for Q4 are holding up a lot better, as the chart below shows.
The chart below shows the overall earnings picture on a calendar-year basis, with the +7.9% earnings growth this year followed by double-digit gains in 2025 and 2026.
Please note that this year’s +7.9% earnings growth improves to +9.8% on an ex-Energy basis.
For a detailed look at the overall earnings picture, including expectations for the coming periods, please check out our weekly Earnings Trends report >>>> Breaking Down the Q3 Earnings Season Scorecard
Zacks Investment Research
The biopharmaceutical sector showed signs of recovery in the third quarter of 2024, fueled by increased investor optimism following the U.S. Federal Reserve’s interest rate cuts in September.
According to GlobalData, the top 20 global biopharmaceutical companies saw a 2% rise in their combined market capitalization, reaching $4.3 trillion by the end of September, up from $4.2 trillion in June.
This rebound highlights the industry’s potential for growth despite challenges earlier in the year.
Bristol-Myers Squibb & Co led the market with the largest increase in capitalization, which surged by 24.6% to $105 billion. This was largely driven by advancements in its pipeline, notably the FDA’s approval of its antipsychotic drug, Cobenfy, for treating schizophrenia in September 2024.
Gilead Sciences Inc also posted impressive growth, rising 22.1% in market value, thanks to the accelerated FDA approval of Livdelzi, a treatment for primary biliary cholangitis, as well as the approval of its antibody-drug conjugate, Trodelvy, for HR-/HER2- breast cancer in Japan.
Sanofi SA experienced a 19.2% jump in market capitalization, largely fueled by its flagship drug Dupixent. The drug’s strong performance in the treatment of conditions such as asthma and atopic dermatitis, coupled with its recent EMA and FDA approvals for chronic obstructive pulmonary disease (COPD), further boosted Sanofi’s standing.
Similarly, AbbVie Inc saw a 15.2% increase in its market cap, driven by the continued success of its immunology drugs—Humira, Skyrizi, and Rinvoq—which together generated nearly $7 billion in Q2 2024 sales.
Alnylam Pharmaceuticals Inc joined the top 20 biopharmaceutical companies with a 14.9% rise in its market value, following its RNAi drug vutrisiran's positive results in treating ATTR amyloidosis with cardiomyopathy.
Roche Holdings AG's market capitalization grew by 13.8%, spurred by the FDA’s approval of two key products, Ocrevus Zunovo for multiple sclerosis and Tecentriq Hybreza for oncology indications, the latter being the only approved subcutaneous PD-L1 inhibitor available.
On the downside, Wegovy maker Novo Nordisk A/S saw an 18.2% drop in its market cap after the FDA rejected its BLA filing for the once-weekly insulin icodec.
Similarly, Eli Lilly & Co reported a slight decline of 2.1%, though both companies retained their leadership in diabetes and weight loss drugs.
Merck & Co Inc also faced a 8.2% fall in market value, largely due to disappointing sales of its HPV vaccine, Gardasil, in China.
"The biopharmaceutical industry is poised for a recovery, fueled by multiple FDA approvals leading to a rebound in companies that have seen declines in market capitalization in previous quarters, such as Gilead Sciences and Bristol-Myers Squibb,” says GlobalData analyst.
Read Next:
Image Via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.